First Time Loading...

Transcode Therapeutics Inc
NASDAQ:RNAZ

Watchlist Manager
Transcode Therapeutics Inc Logo
Transcode Therapeutics Inc
NASDAQ:RNAZ
Watchlist
Price: 1.2 USD 1.69% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Transcode Therapeutics Inc?
Write Note

Transcode Therapeutics Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Transcode Therapeutics Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Transcode Therapeutics Inc
NASDAQ:RNAZ
Retained Earnings
-$46.4m
CAGR 3-Years
-138%
CAGR 5-Years
-146%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$2.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$10.7B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.9B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-15%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$11.2B
CAGR 3-Years
95%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$28B
CAGR 3-Years
33%
CAGR 5-Years
37%
CAGR 10-Years
N/A

See Also

What is Transcode Therapeutics Inc's Retained Earnings?
Retained Earnings
-46.4m USD

Based on the financial report for Dec 31, 2023, Transcode Therapeutics Inc's Retained Earnings amounts to -46.4m USD.

What is Transcode Therapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-146%

Over the last year, the Retained Earnings growth was -67%. The average annual Retained Earnings growth rates for Transcode Therapeutics Inc have been -138% over the past three years , -146% over the past five years .